Department of Biology, York University, Toronto, Ontario, Canada.
Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
Physiology (Bethesda). 2021 May 1;36(3):134-149. doi: 10.1152/physiol.00031.2020.
Adiponectin, an adipokine that circulates as multiple multimeric complexes at high levels in serum, has antidiabetic, anti-inflammatory, antiatherogenic, and cardioprotective properties. Understanding the mechanisms regulating adiponectin's physiological effects is likely to provide critical insight into the development of adiponectin-based therapeutics to treat various metabolic-related diseases. In this review, we summarize our current understanding on adiponectin action in its various target tissues and in cellular models. We also focus on recent advances in two particular regulatory aspects; namely, the regulation of adiponectin gene expression, multimerization, and secretion, as well as extravasation of circulating adiponectin to the interstitial space and its degradation. Finally, we discuss some potential therapeutic approaches using adiponectin as a target and the current challenges facing adiponectin-based therapeutic interventions.
脂联素是一种循环中的脂肪因子,以多种多聚体复合物的形式存在于血清中,具有抗糖尿病、抗炎、抗动脉粥样硬化和心脏保护作用。了解调节脂联素生理作用的机制可能为基于脂联素的治疗方法的发展提供关键的见解,以治疗各种与代谢相关的疾病。在这篇综述中,我们总结了我们目前对脂联素在其各种靶组织和细胞模型中的作用的理解。我们还重点介绍了两个特定调节方面的最新进展;即脂联素基因表达、多聚化和分泌的调节,以及循环脂联素向细胞间隙的外渗及其降解。最后,我们讨论了一些使用脂联素作为靶点的潜在治疗方法和基于脂联素的治疗干预所面临的当前挑战。